Digipharm.io’s marketing strategy

Goals Digipharm.io should focus on

1.

Scale sales qualified leads

2.

Shorten buying cycle with higher intent prospects

3.

Drive waitlist signups for mobile app in development

A quick look at DigiPharm's Competitor, LyfeGen

Lyfegen marketing
  • Lyfegen only runs Linkedin ads, which makes them vulnerable to brands stealing their search traffic. 
  • Competitors are targeting “value based drug pricing” with content. This can easily be a non-branded ad group
  • Lead nurturing ads should target current prospects through custom audience targeting 

What a PPC strategy would look like

1. Use search ads to steal competitor traffic & build sales qualified leads

  • Run branded Google ads bidding on Lyfegen 
  • Build top of funnel Google ads targeting “value based drug pricing” keywords
  • Create custom audience linkedin ads to nurture existing leads
  • Create dedicated landing pages to match ad targeting
  • Protect your brand with branded PPC ads

 

PRO TIP: Ensure your branded Google ads have 90% impression share

 

Sales Funnel

Awareness

Consideration

Comparison

Purchase

Customer's Journey

Has a problem

Identify a solution

Be the best solution

Searches for your brand

Ad campaigns

Competitor ads

nonbranded keywords

Lead nurturing ads

Branded ads

What if Digipharm wants to go DTC?

Digipharm app
  • Facebook could be the cheaper platofrm to drive sign ups, given their CPAs are drastically lower than Linkedin, which is where most competitors play. 
  • Digipharm would need to focus on benefits instead of product features in ad copy
  • Landing page copy would need to reflect the change in ad copy. 

Not getting the results you want?
Get a free consultation.

Picture of Jack Treseler

Jack Treseler

Jack is a serial entrepreneur with a decade of experience in marketing finance brands. Jack believes investing and business can be used for good, and loves helping fintech companies scale their business (and their revenue). He's also a fan of pineapple on pizza, but we won't hold that against him.